Baricitinib

CAS 1187594-09-7

In Stock

Baricitinib

Cat. No. ANT-BRC-00CAS 1187594-09-7In Stock

Technical Data

Cat. No.ANT-BRC-00

CAS1187594-09-7

Mol. FormulaC₁₆H₁₇N₇O₂S

Mol. Weight371.42 g/mol

IUPAC2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile

SMILESCCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3

InChIInChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)

InChI KeyXUZMWHLSFXCVMG-UHFFFAOYSA-N

PurityNA

Description

Overview

Baricitinib, sold under the brand name Olumiant among others, is a drug for the treatment of rheumatoid arthritis (RA) in adults whose disease was not well controlled by tumor necrosis factor (TNF) inhibitors

Anant Labs manufacture and furnish high quality Baricitinib impurities for global markets. Our Baricitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrileBaricitinib1187594-09-7olumiantLY3009104INCB028050INCB 028050INCB-028050LY 3009104LY-3009104

Browse APIs A–Z